Alpha IVF Group Berhad (KLSE:ALPHA) is highlighted for its effective capital allocation, indicated by a growing return on capital employed (ROCE). This suggests strong financial management and a potential for significant returns for investors. Positive factors include efficient use of resources, profitability, and growth potential. Negative factors might involve market saturation in the IVF sector, regulatory changes, or competition. Investors should view this as a positive sign for the company’s long-term prospects. The healthcare and biotechnology sectors, where IVF falls, are influenced by technological advancements and healthcare policies. This falls under ‘healthcare’.